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The effect of fasting on the activation in vivo of the insulin
receptor kinase
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Fasting causes insulin resistance in liver and fat, and increases insulin sensitivity in muscle. We studied the
response in vitro and in vivo to insulin of the insulin receptor tyrosine kinase in muscle and liver from 72 h
fasted and control rats. Insulin was injected intraperitoneally together with glucose, and blood and tissue
samples were obtained 0, 5, 15 and 30 min later. Basal serum glucose and insulin levels were significantly
higher in control than in fasting rats. Serum glucose rose to 300 mg/dl at 5 min and then progressively
declined without hypoglycaemia. Receptors were prepared from whole tissue by wheat germ lectin affinity
chromatography. "25I-insulin binding to purified receptors was increased by fasting in both muscle (18 00)
and liver (50 %O). In untreated fasting and control animals, muscle and liver insulin receptor tyrosine kinase
activity was stimulated to similar levels by insulin added in vitro. With only insulin treatment in vivo, muscle
receptor tyrosine kinase behaved similarly in fasting and control animals with maximal activation at 15 min
post injection. In liver, insulin in vivo stimulated receptor tyrosine kinase activity maximally at 5 min post
injection in both fasting and control, but in fasting animals the treatment in vivo caused a significantly larger
and more prolonged activation of the enzymic activity, possibly due to a decrease in the rate of
dephosphorylation and deactivation of the /3 subunits.
INTRODUCTION
Fasting induces a number of metabolic and endocrine
changes that appear to be tissue specific. In muscle,
fasting causes an increase in sensitivity or responsiveness
to insulin [1,2]. In fat, fasting causes a decrease in basal
and insulin-stimulated glucose transport and utilization
[3-5]. In liver and in isolated hepatocytes, fasting causes
insulin resistance characterized by a lack of response to
the hormone with regard to glucose production [6], lipid
synthesis [7], amino acid uptake [8] and glycogen syn-
thesis [9]. In most tissues studied, insulin binding appears
to be increased during fasting [2,5,8-10] but without
direct relationship between hormone binding and action,
a reason for which post-binding abnormalities are
thought to occur. A possible defective site of insulin
action in the fasting state would be the insulin receptor
tyrosine kinase (for reviews see [1 1-13]), since its activity
is deficient in other states of insulin resistance such as
clinical [14,15] or experimental [16] diabetes and obesity
[17]. Previous reports have shown an increase [10] or a
decrease [18] in receptor phosphorylation in response to
insulin added in vitro to liver receptors purified from
fasted rats. We have studied the response of muscle and
liver receptor tyrosine kinase to insulin added in vitro or
to insulin injected in vivo to 72 h fasted and to normally
fed control rats.
METHODS
Materials
Porcine monocomponent insulin and [Tyr-125I]mono-
iodoinsulin (376,tCi/,ug) were kindly supplied by Eli
Lilly & Co. [32P]ATP (300Ci/mmol) was purchased
from Amersham Corp. Wheat germ agarose, obtained
from Sigma, was prepared from lectin and CNBr-treated
agarose 4B. Hepes, poly(Glu,Tyr) (4: 1), phenylmethane-
sulphonyl fluoride, benzamidine, leupeptin, pepstatin,
aprotinin, bacitracin and Triton X-100 were also from
Sigma. All other chemicals were of analytical grade.
Animals and treatment
Sprague-Dawley rats with initial weights of 150-180 g
were obtained from Charles River Laboratories and
housed for 3-4 days on a 12 h light/dark cycle with free
access to regular lab chow and water. Food was then
removed for 72 h from the animals in the fasting group or
for 2 h in the control group. Animals were then injected
intraperitoneally with a single solution containing insulin
(10 units/kg body weight) and D-glucose (1.5 g/kg body
weight). At different times after the injection, the animals
were decapitated, blood was collected, and whole livers
or whole quadriceps muscles were quickly obtained,
frozen with liquid N2, and stored at -70 ° C for up to
4 weeks until processed; 7-10 animals were studied per
group for each value reported.
Blood analyses
Serum glucose was analysed with a glucose oxidase/
peroxidase method using a kit provided by Sigma.
Immunoreactive insulin was measured using a double-
antibody radioimmunoassay [19].
Isolation of receptors
Tissue (1 g) was powdered frozen and homogenized
(Polytron, 1 min)- in 5 ml of a medium containing Hepes
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(50 mM, pH 7.4), NaCl (50 mM), NaF (1Q00 I U), pyro-
phosphate (10 mM), EDTA (8 mM), vanadate (1 mM),
benzamidine (15 mM), phenylmethanesulphonyl fluoride
(1 mM), Triton X-100 (1 os), leupeptin (2 ,UM), pepstatin
(2 /tM), aprotinin (1000 units/ml) and bacitracin
(1 mg/ml). The homogenates were centrifuged at
100000 g for 90 min at 4° C using a 50.2 Ti Beckman
rotor and the supernatants were diluted 4-fold with a
buffer containing Hepes, NaCl, NaF and pyrophosphate
in the same concentrations noted for the homogenization
buffer. The diluted supernatants were incubated over-
night and mixed at 4 ° C with 3 ml of wheat germ
agglutinin-agarose gel. The gel was then transferred into
disposable plastic columns, and these were washed with
10 bed volumes of a buffer containing Hepes (50 mM),
NaCl (150 mM), Triton X-100 (0.1 o%) and phenyl-methanesulphonyl fluoride (0.1 mM). Elution was
accomplished with 0.3 M-N-acetylglucosamine prepared
in the same washing buffer. Receptor fractions were
immediately divided into aliquots and frozen at -70 ° C
until further analysis.
Binding studies
Binding of 1251-insulin (100000 c.p.m.) to 50 ,l of
purified receptors was performed overnight at 4 ° C in a
total volume of 250 10 in the absence or presence of
unlabelled insulin at different concentrations. Receptors
were then precipitated with poly(ethylene glycol) and
bovine y-globulin and washed twice before counting, as
described previously [21]. Specific binding was calculated
after subtraction of the nonspecific value obtained in the
presence of 1 ,UM unlabelled insulin.
Assay of tyrosine kinase
Tyrosine kinase was analysed as previously described
[21] with minor modifications. Purified receptors (50 ,ul)
were incubated for 30 min at room temperature in the
presence of Hepes (50 mM, pH 7.4), MgCi2 (10 mM),
MnCl2 (0.5 mM), [32P]ATP (100 /M, 1.3 mCi/ml) and
poly(Glu,Tyr) (4:1) (2.5 mg/mI) in a total volume of
150 ,ul in the presence or absence of insulin at different
concentrations. At the end of the incubation period,
100 ,ul of mixture was taken and spotted onto a 2.3 cm
Whatman 3M filter paper disc which was immediately
dropped into 10o trichloroacetic acid containing
10 mM-sodium pyrophosphate. The discs were washed
five times with trichloroacetic acid, then with ethanol,
and finally counted for radioactivity. Reagent blanks
were subtracted. Results were expressed as pmol of
phosphotyrosine/fmol of insulin binding.
Statistics
Results are expressed as means + S.E.M. Control and
fasting groups were compared by Student's t test.
RESULTS
Blood glucose and insulin levels
As illustrated in Fig. 1(a), in non-injected rats (time
zero) blood glucose levels were higher in the control
(169 + 8.0 mg/dl) than in the fasting group
(106 + 3.2 mg/dl, P < 0.01). After intraperitoneal treat-
ment, glucose levels increased to approx. 300 mg/dl at
5 min in both groups and then decreased to about
160 mg/dl at 15 min and to about 75 mg/dl at 30 min,
without significant differences between the two groups
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Fig. 1. Serum glucose (a) and insulin (b) levels
Rats were injected intraperitoneally with insulin (10
units/kg body weight) plus glucose (1.5 g/kg) after either
72 h (fasting, *) or 2 h (control, 0) of fasting. Animals
were decapitated at the time points indicated, and blood
was collected and analysed. *Indicates statistical sig-
nificance of difference between control and fasting (see text
for P values).
compared. Insulin levels (Fig. 1 b) at time zero were
higher in the control (60 ± 4.5,uunits/ml) than in the
fasting group (11.6+ 1.6 juunits/ml, P < 0.001). After
the injection, serum insulin rose to about
1400-1500 #tunits/ml in both groups and remained atthis high level from 5 to 30 min.
15I-insulin binding
Specific "25I-insulin binding to muscle receptors was
7.8+0.3% in control and 9.2+0.5% in fasting (P <
0.01). In liver receptors binding was 31 + 1.1 %0 in controland 46.6 + 0.7 in fasting (P < 0.00 1). Nonspecific binding
was consistently less than 6 0 of total binding. Scatchard
analysis of muscle and liver receptors showed similar
hormone binding kinetics for both groups of animals,
with no difference in hormone-receptor affinity.
Muscle receptor tyrosine kinase
Basal muscle receptor tyrosine kinase in non-injected
animals was 4.3 + 0.40 pmol/fmol in control and
2.2 + 0.6 pmol/fmol in fasting (P < 0.05). When insulin
was added in vitro to these receptors (Fig. 2a), tyrosine
kinase increased in a similar fashion in both the control
and fasting groups, with similar dose-response relation-
ships and maximal activities. In both groups of animals
receptor tyrosine kinase activity increased after the
injection of insulin in vivo (Fig. 2b), reaching a maximum
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Activation in vivo of insulin receptor tyrosine kinase in fasting
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Fig. 2. Muscle receptor tyrosine kinase activity after insulin treatment in vitro (a) or in vivo (b)
Fasted (@) or control (0) rats were treated with insulin plus glucose as described in Fig. 1. Quadriceps muscles were rapidly
frozen in liquid N2, receptors obtained by wheat germ agglutinin-agarose affinity chromatography, and tyrosine kinase was
assayed using poly(Glu,Tyr) (4:1) as the substrate. Insulin was added in vitro in (a) but not in (b).
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Fig. 3. Liver receptor tyrosine kinase activity after insulin treatment in vitro (a) or in vivo (b)
Liver receptor kinase activity was assayed in fasted (X) or control (0) rats as described in Fig. 2. Insulin was added in vitro
in (a) but not in (b). *Indicates statistical significance of difference between control and fasting (see text for P values).
at 15 min that was maintained at 30 min, when the
activities were 11.8 + 0.50 pmol/fmol for control and
13.4 + 2.5 pmol/fmol for fasting, with no statistical differ-
ences.
Liver receptor tyrosine kinase
Basal activity of liver receptor tyrosine kinase in non-
injected animals was 2.16 + 0.20 pmol/fmol in control
and 1.43 + 0.14 pmol/fmol in fasting (P < 0.05). When
insulin was added in vitro to these receptors, tyrosine
kinase activity increased in a similar fashion in the
control and fasting groups (Fig. 3a) with similar dose-
response relationships and maximal activities. In control
animals treated with insulin in vivo (Fig. 3b) the liver
enzyme was rapidly activated, reaching a maximal ac-
tivity of 3.9 + 0.40 pmol/fmol at 5 min after the injection,
and then declining to 3.0 + 0.36 pmol/fmol at 15 min and
2.6 + 0.4 pmol/fmol at 30 min. In fasting animals, the
treatment in vivo caused a significantly larger and more
prolonged activation of the liver receptor kinase, with
activities of 5.6 +0.7 pmol/fmol at 5 min (P < 0.05),
6.3+0.26 pmol/fmol at 15 min (P < 0.001) and
4.1 + 0.40 pmol/fmol at 30 min (P < 0.05). P values refer
to differences between control and fasting.
DISCUSSION
Starvation causes a number ofmetabolic and endocrine
changes that may be considered as an adaptative strategy
aimed at increasing the chance of survival. After 48-72 h
of fasting, insulin responses in fat [3-5] and liver [6-9]
appear to decrease, whereas those of muscle appear to
increase [1,2]. Thus, in the event of a transient absorption
of food with insulin release, sugars and amino acids will
probably be directed to muscle where they may be
immediately required, while liver continues neogluco-
genesis and glucose output to ensure its long-term
availability. The molecular events responsible for these
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changes in insulin responses during fasting remain largely
unknown. We have assessed the response of muscle and
liver receptor tyrosine kinase to insulin added in vitro as
well as to insulin injected in vivo to the intact animals.
Insulin was rapidly absorbed into the circulation after its
intraperitoneal injection, as indicated by the high blood
levels detected at the earliest post-injection time studied
(5 min) and remained at this high concentration through-
out the 30 min of the experiment. The addition of glucose
to the insulin treatment prevented the development of
hypoglycaemia, which would have triggered undesired
compensatory changes in other hormonal systems. The
deliberately caused hyperglycaemia should not have
interfered with the action of insulin on its receptors, since
glucose itself does not affect the activity of the kinase.
Our results showed normal muscle receptor tyrosine
kinase activation by treatment either in vitro or in vivo
with insulin, thus providing no evidence for any changes
in this enzymic activity with the changes in muscle insulin
response that appear to occur during fasting. The fact
that the basal activity of the receptor kinase in muscle
was higher in control than in fasting animals presumably
reflects the higher basal blood levels of insulin present in
the control animals. Insulin binding by liver receptors
was increased in fasting animals by 500 due to an
increase in receptor numbers, in agreement with previous
reports [8-10]. Our results with liver show normal ac-
tivation of receptor tyrosine kinase by insulin added in
vitro, thus differing from those of Freidenberg et al. [18],
who reported a decrease in this enzymic activity in
receptors isolated from liver plasma membranes obtained
from 72 h fasted animals. Our discrepancy with this
previous work may be related to the fact that we isolated
receptors from whole tissue and not only from a plasma
membrane fraction. Fasting enhances lysosomal activity
in liver [20,21] and causes changes in the sedimentation
properties of liver subcellular fractions [20,22], and these
factors may have contributed to produce the abnormally
low tyrosine kinase activity reported for fasting liver
receptors in the previous work already cited. We used a
more rapid, whole-tissue extraction of the receptors and
added four different protease inhibitors and four phos-
phatase inhibitors during the extraction procedure, which
may have resulted in a receptor preparation that better
represents the status in vivo in the whole cells. These
differences in procedures may partly explain the differ-
ences in results. On the other hand, the fact that in our
study the activation in vitro of liver insulin receptor
tyrosine kinase is normal, whereas the activation in vivo
is abnormally high, suggests that the rate of de-
phosphorylation (and inactivation) of the liver receptor
tyrosine kinase may be decreased in the liver during
fasting. Dephosphorylation of the insulin receptor may
occur after internalization [23,24] and one might specu-
late that perhaps a slowing of the process of internal-
ization, dephosphorylation and recycling of the insulin
receptor occurs in liver during fasting. This would limit
the capacity of the cells to respond to insulin [25] while
causing the buildup of internalized, non-deactivated
receptors, giving rise to the puzzling paradox of having
liver insulin resistance with a seemingly hyper-responsive
receptor tyrosine kinase.
We thank Mr. Edward Tapscott for performing the blood
glucose and insulin analyses. This work was supported by
grants DK38416 and DK36296 from NIH, and grant M109287
from CDCH-VCV, Caracas. I. C. was the recipient of a
Fogarty International fellowship.
REFERENCES
1. Goodman, M. N. & Ruderman, N. B. (1979) Am. J.
Physiol. 236, E519-E523
2. Brady, L. J., Goodman, M. N., Kalish, F. N. & Ruderman,
N. B. (1981) Am. J. Physiol. 240, E184-El90
3. Kahn, A. V., Simpson, I. A. & Cushman, S. W. (1988)
J. Clin. Invest. 82, 691-699
4. Kasuga, M., Akanuma, Y., Iwamoto, Y. & Kosaka, K.
(1977) Endocrinology (Baltimore) 100, 1384-1390
5. Olefsky, J. M. (1976) J. Clin. Invest. 58, 1450-1460
6. Penicaud, L., Kande, J., Le-Magnen, J. & Girard, J. R.
(1985) Am. J. Physiol. 249, E514-E518
7. Caro, J. F. & Amatruda, J. M. (1982) Metabolism 31,
14-18
8. Cech, J. M., Freeman, R. B., Jr., Caro, J. F. & Amatruda,
J. M. (1980) Biochem. J. 188, 839-845
9. Trowbridge, M., Sussman, A., Ferguson, L., Draznin, B.,
Neufeld, N., Begum, N., Tepperman, H. & Tepperman, J.
(1984) Mol. Cell. Biochem. 62, 25-36
10. Blackshear, P. S., Nemenoff, R. A. & Avruch, J. (1984)
Endocrinology (Baltimore) 114, 141-152
11. Czech, M. P. (1985) Annu. Rev. Physiol. 47, 357-381
12. Goldfine, I. D. (1987) Endocr. Rev. 8, 233-255
13. Kahn, C. R. & White, M. F. (1988) J. Clin. Invest. 82,
1151-1156
14. Caro, J. F., Ittoop, O., Pories, W. J., Meelheim, D.,
Flickinger, E. G., Thomas, F., Jenkin, M., Silverman,
J. F., Khazanie, P. G. & Sinha, M. K. (1986) J. Clin. Invest.
77, 1716-1718
15. Friedenberg, G. R., Henry, R. R., Klein, H. H., Reichart,
D. R. & Olefsky, J. M. (1987) J. Clin. Invest. 79, 240-250
16. Gherzi, R., Andraghetti, G., Ferrannini, E. & Cordera, R.
(1986) Biochem. Biophys. Res. Commun. 140, 850-856
17. Caro, J. F., Pories, W. J., Flickinger, E. G., Meelheim, D.,
Ittoop, O., Jenquin, M., Sinha, M. K. & Dohm, G. L.
(1987) J. Clin. Invest. 79, 1330-1337
18. Freidenberg, G. R., Klein, H. H., Cordera, R. & Olefsky,
J. M. (1985) J. Biol. Chem. 260, 12444-12453
19. Morgan, C. R. M. & Lazarow, A. (1963) Diabetes 12,
115-126
20. Harikumar, P. & Ninjoor, V. (1979) Biochim. Biophys.
Acta 587, 60-66
21. Kasperek, G. J., Dohm, G. L., Tapscott, E. B. & Powell,
T. (1980) Proc. Soc. Exp. Biol. Med. 164, 430-434
22. Pokrovsky, A. A., Tashev, T. A., Krustev, L. P., Tutelyan,
V. A. & Kravchenko, L. V. (1976) Int. J. Vitam. Nutr. Res.
46, 75-82
23. Bergerom, J. J. M., Lai, W. H., Kay, D. G., Doherty, J. J.,
Khan, M. N. & Posner, B. I. (1988) Adv. Exp. Med. Biol.
234, 213-224
24. Backer, J. M., Kahn, C. R. & White, M. F. (1989) J. Biol.
Chem. 264, 1694-1701
25. Contreras, I. & Caro, J. F. (1989) Trends Biochem. Sci. 14,
399
1990
Received 19 July 1989/31 October 1989; accepted 16 November 1989
890
